Current Report

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported) May 14, 2005

 


 

STERIS Corporation

(Exact name of registrant as specified in its charter)

 


 

Ohio   1-14643   34-1482024

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

5960 Heisley Road, Mentor, Ohio   44060-1834
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code (440) 354-2600

 

Not Applicable

(Former name or former address, if changed since last report.)

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



ITEM 1.01. Entry into a Material Definitive Agreement.

 

Annual Incentive Compensation Plan Awards

 

On May 14, 2005, the Compensation and Corporate Governance Committee (the “Committee”) of the Board of Directors (the “Board”) of STERIS Corporation (“STERIS” or the “Company”) approved annual cash incentive awards for fiscal 2005 under STERIS’s Senior Executive Management Incentive Compensation Plan (“SEMICP”) and Management Incentive Compensation Plan (“MICP”) to certain members of management, including the following awards to the named executive officers: Les C. Vinney, $450,000; Laurie Brlas, $117,500; Peter A. Burke, $117,500; Gerard J. Reis, $100,000; and Charles L. Immel, $127,500.

 

Annual cash incentive compensation payments under the Company’s incentive compensation plans are generally based on the achievement of financial goals, as well as achievement of individual objectives. For fiscal 2005, the financial goals were based on a combination of the following: Company and/or segment (depending upon the responsibilities of the executive officer) revenue, Company free cash flow, Company earnings before interest and taxes (EBIT) and business segment contribution margin. In addition, to receive the incentive compensation payments, executive officers also were required to achieve individual performance objectives. Incentive compensation goals and objectives and award opportunities for each executive officer are fixed at the beginning of the fiscal year and are based on the responsibilities of the executive officer’s position and the competitive marketplace. The annual incentive awards specified above were based on the Committee’s determination of the extent to which the performance measures for fiscal year 2005 had been achieved.

 

Both the SEMICP and the MICP were previously filed by the Company as Exhibits 10.9 and 10.8, respectively, to its Annual Report on Form 10-K for the year ended March 31, 2004.

 

Annual Management Incentive Compensation Plan Criteria

 

Also on May 14, 2005, the Committee approved performance objectives for annual cash incentive payments under the MICP for the fiscal year ending March 31, 2006, which also will be based on the achievement of financial performance goals, as well as achievement of individual objectives. The financial performance objectives under the MICP will be based on a combination of the following: Company and/or segment revenue, Company free cash flow, Company earnings before interest and taxes (EBIT) and business segment contribution margin.

 

2


ITEM 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

 

On May 14, 2005, Dr. Jerry E. Robertson resigned as Chairman of the Board and announced that he was retiring as a Director effective as of the Annual Meeting of Shareholders to be held on or about July 29, 2005. The Board appointed Mr. John P. Wareham as the new Chairman, succeeding Dr. Robertson. A copy of the press release announcing these events is attached hereto as Exhibit 99.1

 

ITEM 8.01. Other Events.

 

Quarterly Dividend Authorized

 

On May 14, 2005, the Board also authorized the payment of a quarterly dividend in the amount of $0.04 per share. The dividend is payable June 28, 2005 to shareholders of record at the closing of the stock transfer books on May 31, 2005. A copy of the press release announcing this action is attached hereto as Exhibit 99.2

 

Election of Officers

 

On April 28, 2005, the Board of Directors elected the following officers of STERIS Corporation:

 

Les C. Vinney

   President and Chief Executive Officer

Laurie Brlas

   Senior Vice President and Chief Financial Officer

Peter A. Burke

   Senior Vice President and Chief Technology Officer

Charles L. Immel

   Senior Vice President and Group President, Healthcare

Gerard J. Reis

   Senior Vice President and Group President, Life Sciences

Robert E. Moss

   Senior Vice President and Group President, STERIS Isomedix Services

Mark D. McGinley

   Senior Vice President, General Counsel, and Secretary

Patrick J. McCullagh

   Vice President, Global Quality Systems Engineering and Regulatory Affairs

William L. Aamoth

   Vice President and Corporate Treasurer

Michael J. Tokich

   Vice President and Corporate Controller

J. Adam Zangerle

   Assistant Secretary

Dennis P. Patton

   Assistant Secretary

Roy L. Turnell

   Assistant Secretary

 

3


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

STERIS CORPORATION
By:  

/s/ Laurie Brlas


    Laurie Brlas
    Senior Vice President and Chief Financial Officer

 

Date: May 19, 2005

 

4


EXHIBIT INDEX

 

Exhibit

Number


 

Exhibit Description


99.1   Press Release issued by STERIS Corporation on May 17, 2005 regarding its Board of Directors Appointment of Mr. John P. Wareham as Chairman of the Board of Directors effective May 14, 2005.
99.2   Press Release issued by STERIS Corporation on May 17, 2005 regarding its Board of Directors Authorization of a Quarterly Dividend.

 

5